Cord Blood Cells. What is this?

Quite simply put, these are cells that are derived from human Umbilical Cords after a natural full term birth. These cells generally number 100,000 to 300,000, but this is not enough for quantum healing. Skilled Progenacell doctors culture these cells in FDA approved laboratories to amounts of 20-50 million. These young, potent cells have the capability of traveling to injured, diseased and degenerative areas of the body and bringing about healthy changes.

Are they safe?

Yes. While Cord Blood Cells have only recently begun to get attention, they were approved by the FDA in the late 1980's for use in certain diseases. Since then a host of laboratory and human-use studies have been carried out that point to the fact that these cells have merit in treating blood diseases, autoimmune conditions including MS, viral conditions and neurodegenerative diseases.

Xeno Transplantation. What is this?

Xeno cells involve the transfer of living cells, tissues or organs between different species of animals. These cells of different species are so similar that they can be used between all species. This concept was developed in 1930 In Switzerland using animal fetal (newborn calf) tissue fragments to treat humans under the established principle "Like treats Like." Xeno transplants have evolved today to become one of the most highly successful alternative treatments used for the regeneration and healing of numerous human diseases. Referred to as "Growth Factors," these organ specific cells stimulate the cells within your own body to assist in their repair and regeneration. When your body is invaded by poisons, toxins, bacteria, and viruses the necessary Peptides or "Growth Factors" in an aging body may not be available in adequate quantities to heal damaged organs.

Are they Safe?

Yes. While the US FDA has not officially approved these cells, the German BfR has. Progenacell physicians have been administering Growth Factors for over 30 years. Numerous case studies have been recorded in both Germany and China (see library) with highly favorable outcomes. Because these cells are so young they have not yet developed an immune system, so there is a seamless transfer to humans with no rejection or allergic reaction.


Progenitor xenotransplantation has preceded organ transplantation by several decades, and will dominate 21st century medicine because:

  • Progenitor xenotransplantation has preceded organ transplantation by several decades, and will dominate 21st century medicine because:
  • Due to the "homing" factor, cells do not require implantation directly into the damaged organ (e.g. liver stem cells into liver), rather implantation can occur in superficial tissues, (e.g. under the abdominal muscle or in the buttocks).
  • Every diseased organ in the human body can be treated by progenitor stem cell transplantation.
  • Besides replacing dead cells of a diseased organ, transplanted cells can bring life back to, or repair those cells which have not died but rather stopped functioning.
  • Properly prepared stem cells do not require any immuno-suppression drugs.
  • Drug therapies are not as broad as any of the 200+ known types of cells that can be transplanted into the body.
  • Drug therapies are used to modify a specific function, and their effect is narrowly focused.

There are two schools of thought in the field of stem cell transplantation today:

  • The US approach, wherein only one cell type is used for treatment, e.g. pancreatic islet cells to treat diabetes mellitus and diabetic complications, such as retinopathy, nephropathy, neuropathy, diabetic vascular disease, etc, or:
  • In the German approach, the patient receives simultaneous transplantation of several types of stem cells, with the choice of transplanted cells depending on the patho-physiology of the patient's disease. As an example, a patient with type 1 (insulin-dependent) diabetes mellitus with complications will usually receive - besides pancreatic islet cells - five other cell types of those organs or tissues no longer functioning properly because of lasting metabolic abnormality caused by this disease. In summary, the German approach requires the treatment be "individualized" by tailoring a combination of stem cell transplants to the specific disease of a specific patient.
  • To Hear from a ProGenaCell Representative

    Fill out an Information Request Form Today! How can we help?